BibTex RIS Kaynak Göster

Magnetic resonance cholangio-pancreatography

Yıl 2012, , 213 - 215, 01.12.2012
https://doi.org/10.5505/sakaryamj.2012.65487

Öz

Magnetic resonance cholangiopancreatography (MRCP) is a noninvasive technique for evaluating the intrahepatic and extrahepatic bile ducts and the pancreatic duct. In the diagnosis pancreatic and bile ducts disorders, MRCP is a much less invasive investigation and does not require contrast material to be administered into the ductal system when compared to endoscopic retrograde cholangiopancreatography (ERCP).

Kaynakça

  • Wallner BK, Schumacher KA, Weidenmeier W, Friedrich JM. Dilated biliary tract: evaluation with MR cholangiography with a T2-weighted contrastenhanced fast sequence. Radiology 1991; 181: 805-808.
  • Coakley FV, Qayyum A. Magnetic resonance cholangiopancrea- tography. Gastrointest Endosc 2002;55:S2–12.
  • Sahai AV, Devonshire D, Yeoh KG. The decisionmaking value of magnetic resonance cholangiopancreatography in patients seen in a referral center with suspected biliary and pancreatic disease. Am J Gastroenterol 2001; 96:207–80.
  • Bowes MT, Martin DF, Melling A, Roberts D, Laasch HU, Suku- mar S, Morris J. Single dose oral ranitidine improves MRCP im- age quality: a double-blind study. Clin Radiol 2007; 62:53.
  • Dalal PU, Howlett DC, Sallomi DF, Marchbank ND, Watson GM, Marr A, Dunk AA, Smith AD. Does intravenous glucagon improve common bile duct visualisation during magnetic resonance chol- angiopancreatography? Results in 42 patients. Eur J Radiol 2004; 49:258.
  • Maccioni F, Martinelli M, Al Ansari N, Kagarmanova A, De Marco V, Zippi M, Marini M. Magnetic resonance cholangiography: past, present and future: a review.. Eur Rev Med Pharmacol Sci. 2010 Aug;14(8):721-5
  • Hochwald SN, Rofsky NM, Dobryanski M, Shamamian P, Marcus SG. MR imaging with MR cholangiopancreatography accurately predicts resectability of pancreatic carcinoma.J Gastrointest Surg1999; 3:506-511
  • Bret PM, Reinhold C. Magnetic resonance cholangiopancreatog- raphy. Endoscopy 1997; 29:472.
  • Reinhold C, Bret PM. Current status of MR cholangiopancreatog- raphy. AJR Am J Roentgenol 1996; 166:1285. Gündüz ve Ark.
  • Magnetic Resonance Cholangiopancreatography
  • Sakaryamj 2012;2(4):213-215
  • Farrell RJ, Noonan N, Mahmud N, Morrin MM, Kelleher D, Keel- ing PW. Potential impact of magnetic resonance cholangiopan- creatography on endoscopic retrograde cholangiopancreatogra- phy workload and complication rate in patients referred because
  • of abdominal pain. Endoscopy 2001;33:668–75.
  • Lomas DJ, Gimson A. Magnetic resonance cholangiopancreatog- raphy [review]. Hosp Med 2000;61:395–9.

Magnetic resonance cholangio-pancreatography

Yıl 2012, , 213 - 215, 01.12.2012
https://doi.org/10.5505/sakaryamj.2012.65487

Öz

Magnetic resonance cholangiopancreatography (MRCP) is a noninvasive technique for evaluating the intrahepatic and extrahepatic bile ducts and the pancreatic duct. In the diagnosis pancreatic and bile ducts disorders, MRCP is a much less invasive investigation and does not require contrast material to be administered into the ductal system when compared to endoscopic retrograde cholangiopancreatography (ERCP).

Kaynakça

  • Wallner BK, Schumacher KA, Weidenmeier W, Friedrich JM. Dilated biliary tract: evaluation with MR cholangiography with a T2-weighted contrastenhanced fast sequence. Radiology 1991; 181: 805-808.
  • Coakley FV, Qayyum A. Magnetic resonance cholangiopancrea- tography. Gastrointest Endosc 2002;55:S2–12.
  • Sahai AV, Devonshire D, Yeoh KG. The decisionmaking value of magnetic resonance cholangiopancreatography in patients seen in a referral center with suspected biliary and pancreatic disease. Am J Gastroenterol 2001; 96:207–80.
  • Bowes MT, Martin DF, Melling A, Roberts D, Laasch HU, Suku- mar S, Morris J. Single dose oral ranitidine improves MRCP im- age quality: a double-blind study. Clin Radiol 2007; 62:53.
  • Dalal PU, Howlett DC, Sallomi DF, Marchbank ND, Watson GM, Marr A, Dunk AA, Smith AD. Does intravenous glucagon improve common bile duct visualisation during magnetic resonance chol- angiopancreatography? Results in 42 patients. Eur J Radiol 2004; 49:258.
  • Maccioni F, Martinelli M, Al Ansari N, Kagarmanova A, De Marco V, Zippi M, Marini M. Magnetic resonance cholangiography: past, present and future: a review.. Eur Rev Med Pharmacol Sci. 2010 Aug;14(8):721-5
  • Hochwald SN, Rofsky NM, Dobryanski M, Shamamian P, Marcus SG. MR imaging with MR cholangiopancreatography accurately predicts resectability of pancreatic carcinoma.J Gastrointest Surg1999; 3:506-511
  • Bret PM, Reinhold C. Magnetic resonance cholangiopancreatog- raphy. Endoscopy 1997; 29:472.
  • Reinhold C, Bret PM. Current status of MR cholangiopancreatog- raphy. AJR Am J Roentgenol 1996; 166:1285. Gündüz ve Ark.
  • Magnetic Resonance Cholangiopancreatography
  • Sakaryamj 2012;2(4):213-215
  • Farrell RJ, Noonan N, Mahmud N, Morrin MM, Kelleher D, Keel- ing PW. Potential impact of magnetic resonance cholangiopan- creatography on endoscopic retrograde cholangiopancreatogra- phy workload and complication rate in patients referred because
  • of abdominal pain. Endoscopy 2001;33:668–75.
  • Lomas DJ, Gimson A. Magnetic resonance cholangiopancreatog- raphy [review]. Hosp Med 2000;61:395–9.
Toplam 14 adet kaynakça vardır.

Ayrıntılar

Birincil Dil Türkçe
Bölüm Makaleler
Yazarlar

Yasemin Gündüz Bu kişi benim

Mustafa Kara Bu kişi benim

Yayımlanma Tarihi 1 Aralık 2012
Gönderilme Tarihi 7 Eylül 2015
Yayımlandığı Sayı Yıl 2012

Kaynak Göster

AMA Gündüz Y, Kara M. Magnetic resonance cholangio-pancreatography. Sakarya Tıp Dergisi. Aralık 2012;2(4):213-215. doi:10.5505/sakaryamj.2012.65487

30703

SMJ'de yayınlanan makaleler, Creative Commons Atıf-GayriTicari 4.0 Uluslararası Lisansı kapsamında lisanslanır